Related Experiment Video
Updated: Jun 2, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Trends in HIV Viral Suppression in the POP-UP Low-Barrier Care Program for People With HIV Experiencing Homelessness
Elizabeth Imbert1, Lisa Fleming1, Jon Oskarsson1
1Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, SanFrancisco, San Francisco, California, USA.
Background:
Human immunodeficiency virus (HIV) viral suppression remains suboptimal among people with HIV (PWH) facing barriers such as homelessness, substance use, and mental health disorders. In 2019, Ward 86 launched the POP-UP program, a low-barrier HIV care model serving PWH with unstable housing and difficulty engaging in care. In 2021, we introduced long-acting antiretroviral therapy (LA-ART), including for PWH unable to attain viral suppression on oral antiretroviral therapy. This study evaluates temporal trends in viral suppression and mortality rates within the POP-UP program.
Methods:
We conducted a retrospective cohort study of PWH enrolled in the POP-UP program between August 2019 and December 2024. Eligibility included viremia (HIV viral load ≥200 copies/mL) or being off antiretroviral therapy, homelessness/unstable housing, and difficulty engaging in care. Criteria later expanded to include PWH with severe mental health or substance use disorders. The primary outcomes were viral suppression (<200 copies/mL) and death.
Results:
Among 241 PWH ever enrolled in POP-UP, 86% attained viral suppression at least once during follow-up. Cross-sectional viral suppression was 47% in August 2019 (8 months after program inception) and increased to 64% in December 2024. By December 2024, 46% of suppressed patients were on LA-ART. The mortality rate declined from 8.8/100 person-years in 2020 to 2.6/100 person-years in 2024, with reductions in both AIDS-related and overdose deaths.
Conclusions:
The POP-UP program improved viral suppression and may have reduced the mortality rate among PWH with substantial barriers to care. Improvements were likely driven by integration of LA-ART and continued quality improvement. Persistent viremia within the program highlights the need for additional strategies to address structural and psychosocial barriers.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Subviral Agents

